Adocia is Extending its Intellectual Property to New Formulations of Monoclonal Antibodies

Product News   Oct 23, 2012

 
Adocia is Extending its Intellectual Property to New Formulations of Monoclonal Antibodies
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Pall Corporation Introduces Proprietary Bioreactor Control System

Product News

Pall Corporation presents mPath™ bioreactor control system, the first-of-its-kind to deliver accurate and controlled single-use process development-scale bioprocesses.

READ MORE

Optibrium, Bugworks Sign Agreement for StarDrop License

Product News

Antimicrobial resistance Biopharma, Bugworks Research selects StarDrop License to guide discovery of next generation of antibiotic.

READ MORE

ELISA-like Assay for Hyaluronic Acid

Product News

AMSBIO launches new Hyaluronic Acid Quantification Kit based on a tightly binding protein to detect and measure Hyaluronic Acid.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE